Rui Zhang1, Gyorgy Simon2, Fang Yu3. 1. Institute for Health Informatics and College of Pharmacy, University of Minnesota, Minneapolis, MN, United States. Electronic address: zhan1386@umn.edu. 2. Institute for Health Informatics and Department of Medicine, University of Minnesota, Minneapolis, MN, United States. Electronic address: simo0342@umn.edu. 3. School of Nursing, University of Minnesota, Minneapolis, MN, United States. Electronic address: yuxxx244@umn.edu.
Abstract
OBJECTIVE: To review the current state of science using big data to advance Alzheimer's disease (AD) research and practice. In particular, we analyzed the types of research foci addressed, corresponding methods employed and study findings reported using big data in AD. METHOD: Systematic review was conducted for articles published in PubMed from January 1, 2010 through December 31, 2015. Keywords with AD and big data analytics were used for literature retrieval. Articles were reviewed and included if they met the eligibility criteria. RESULTS: Thirty-eight articles were included in this review. They can be categorized into seven research foci: diagnosing AD or mild cognitive impairment (MCI) (n=10), predicting MCI to AD conversion (n=13), stratifying risks for AD (n=5), mining the literature for knowledge discovery (n=4), predicting AD progression (n=2), describing clinical care for persons with AD (n=3), and understanding the relationship between cognition and AD (n=3). The most commonly used datasets are AD Neuroimaging Initiative (ADNI) (n=16), electronic health records (EHR) (n=11), MEDLINE (n=3), and other research datasets (n=8). Logistic regression (n=9) and support vector machine (n=8) are the most used methods for data analysis. CONCLUSION: Big data are increasingly used to address AD-related research questions. While existing research datasets are frequently used, other datasets such as EHR data provide a unique, yet under-utilized opportunity for advancing AD research.
OBJECTIVE: To review the current state of science using big data to advance Alzheimer's disease (AD) research and practice. In particular, we analyzed the types of research foci addressed, corresponding methods employed and study findings reported using big data in AD. METHOD: Systematic review was conducted for articles published in PubMed from January 1, 2010 through December 31, 2015. Keywords with AD and big data analytics were used for literature retrieval. Articles were reviewed and included if they met the eligibility criteria. RESULTS: Thirty-eight articles were included in this review. They can be categorized into seven research foci: diagnosing AD or mild cognitive impairment (MCI) (n=10), predicting MCI to AD conversion (n=13), stratifying risks for AD (n=5), mining the literature for knowledge discovery (n=4), predicting AD progression (n=2), describing clinical care for persons with AD (n=3), and understanding the relationship between cognition and AD (n=3). The most commonly used datasets are AD Neuroimaging Initiative (ADNI) (n=16), electronic health records (EHR) (n=11), MEDLINE (n=3), and other research datasets (n=8). Logistic regression (n=9) and support vector machine (n=8) are the most used methods for data analysis. CONCLUSION: Big data are increasingly used to address AD-related research questions. While existing research datasets are frequently used, other datasets such as EHR data provide a unique, yet under-utilized opportunity for advancing AD research.
Authors: Rachel L Richesson; Shelley A Rusincovitch; Douglas Wixted; Bryan C Batch; Mark N Feinglos; Marie Lynn Miranda; W Ed Hammond; Robert M Califf; Susan E Spratt Journal: J Am Med Inform Assoc Date: 2013-09-11 Impact factor: 4.497
Authors: Paul B Rosenberg; Michelle M Mielke; Brian S Appleby; Esther S Oh; Yonas E Geda; Constantine G Lyketsos Journal: Am J Geriatr Psychiatry Date: 2013-02-06 Impact factor: 4.105
Authors: Mili Parikh; Linda S Hynan; Myron F Weiner; Laura Lacritz; Wendy Ringe; C Munro Cullum Journal: Clin Neuropsychol Date: 2014-08-18 Impact factor: 3.535
Authors: Sergi G Costafreda; Ivo D Dinov; Zhuowen Tu; Yonggang Shi; Cheng-Yi Liu; Iwona Kloszewska; Patrizia Mecocci; Hilkka Soininen; Magda Tsolaki; Bruno Vellas; Lars-Olof Wahlund; Christian Spenger; Arthur W Toga; Simon Lovestone; Andrew Simmons Journal: Neuroimage Date: 2011-01-25 Impact factor: 6.556
Authors: Sajjad Fouladvand; Michelle M Mielke; Maria Vassilaki; Jennifer St Sauver; Ronald C Petersen; Sunghwan Sohn Journal: Proceedings (IEEE Int Conf Bioinformatics Biomed) Date: 2020-02-06
Authors: Larry Zhang; Anthony Ngo; Jason A Thomas; Hannah A Burkhardt; Carolyn M Parsey; Rhoda Au; Reza Hosseini Ghomi Journal: Explor Med Date: 2021-06-30
Authors: Erik D Huckvale; Matthew W Hodgman; Brianna B Greenwood; Devorah O Stucki; Katrisa M Ward; Mark T W Ebbert; John S K Kauwe; Justin B Miller Journal: Genes (Basel) Date: 2021-10-21 Impact factor: 4.096
Authors: Jie Xu; Fei Wang; Zhenxing Xu; Prakash Adekkanattu; Pascal Brandt; Guoqian Jiang; Richard C Kiefer; Yuan Luo; Chengsheng Mao; Jennifer A Pacheco; Luke V Rasmussen; Yiye Zhang; Richard Isaacson; Jyotishman Pathak Journal: Learn Health Syst Date: 2020-09-10